Bronchitol Paediatric Cystic Fibrosis Clinical Trial Reports Positive Results

16th Dec 15

Release Date: 16/12/2015 12:00am

Pharmaceutical research company Pharmaxis (ASX: PXS) is pleased to announce positive results of its recently completed Phase II trial of BronchitolĀ® (mannitol) in children and adolescents with cystic fibrosis (CF). The trial, conducted across 39 global centres, met its primary endpoint and confirms that Bronchitol is efficacious in young patients, regardless of concomitant dornase alfa use.

Read full media release - pdf

Categories: News and Media